Redmile as of June 30, 2016
Portfolio Holdings for Redmile
Redmile holds 54 positions in its portfolio as reported in the June 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Array BioPharma | 6.5 | $68M | 19M | 3.56 | |
| Amicus Therapeutics (FOLD) | 5.8 | $61M | 11M | 5.46 | |
| Medivation | 5.3 | $56M | 930k | 60.30 | |
| Seattle Genetics | 5.3 | $56M | 1.4M | 40.41 | |
| Atara Biotherapeutics | 5.2 | $54M | 2.4M | 22.51 | |
| Penumbra (PEN) | 4.9 | $51M | 864k | 59.50 | |
| Endologix | 4.7 | $49M | 4.0M | 12.46 | |
| Clovis Oncology | 4.1 | $43M | 3.1M | 13.72 | |
| Molina Healthcare (MOH) | 4.0 | $42M | 845k | 49.90 | |
| Intra Cellular Therapies (ITCI) | 3.6 | $38M | 972k | 38.82 | |
| Portola Pharmaceuticals | 3.3 | $35M | 1.5M | 23.60 | |
| Nevro (NVRO) | 2.8 | $29M | 398k | 73.76 | |
| Boston Scientific Corporation (BSX) | 2.8 | $29M | 1.2M | 23.37 | |
| SPDR S&P Biotech (XBI) | 2.5 | $27M | 491k | 54.09 | |
| Model N (MODN) | 2.4 | $25M | 1.9M | 13.35 | |
| BioMarin Pharmaceutical (BMRN) | 2.4 | $25M | 322k | 77.80 | |
| Nanostring Technologies (NSTGQ) | 2.4 | $25M | 1.9M | 12.60 | |
| Incyte Corporation (INCY) | 2.3 | $24M | 302k | 79.98 | |
| Brookdale Senior Living (BKD) | 2.3 | $24M | 1.5M | 15.44 | |
| Alexion Pharmaceuticals | 2.3 | $24M | 202k | 116.76 | |
| HeartWare International | 2.2 | $23M | 406k | 57.75 | |
| Wave Life Sciences (WVE) | 2.2 | $23M | 1.1M | 20.69 | |
| Aetna | 2.1 | $22M | 183k | 122.13 | |
| Centene Corporation (CNC) | 1.9 | $20M | 285k | 71.37 | |
| Prothena (PRTA) | 1.6 | $17M | 487k | 34.96 | |
| Syros Pharmaceuticals | 1.4 | $15M | 946k | 15.91 | |
| Neuroderm Ltd F | 1.3 | $13M | 821k | 16.25 | |
| Chimerix (CMRX) | 1.2 | $13M | 3.3M | 3.93 | |
| Oxford Immunotec Global | 1.2 | $13M | 1.4M | 9.00 | |
| Charles River Laboratories (CRL) | 1.0 | $11M | 132k | 82.44 | |
| Adeptus Health Inc-class A | 0.8 | $8.4M | 164k | 51.66 | |
| Press Ganey Holdings | 0.8 | $7.8M | 198k | 39.35 | |
| Spectranetics Corporation | 0.7 | $7.5M | 402k | 18.71 | |
| Cytomx Therapeutics (CTMX) | 0.7 | $7.5M | 734k | 10.22 | |
| Envision Healthcare Hlds | 0.7 | $7.3M | 289k | 25.37 | |
| Conformis | 0.7 | $7.4M | 1.0M | 7.02 | |
| PharMerica Corporation | 0.6 | $6.5M | 264k | 24.66 | |
| VCA Antech | 0.6 | $6.4M | 94k | 67.61 | |
| eHealth (EHTH) | 0.6 | $6.0M | 426k | 14.02 | |
| Ironwood Pharmaceuticals (IRWD) | 0.6 | $5.8M | 443k | 13.07 | |
| American Renal Associates Ho | 0.4 | $4.3M | 150k | 28.97 | |
| Invitae (NVTAQ) | 0.4 | $4.0M | 545k | 7.39 | |
| Array Biopharma Inc note 3.000% 6/0 | 0.3 | $3.4M | 4.0M | 0.85 | |
| Proqr Thrapeutics N V shs euro (PRQR) | 0.3 | $2.8M | 582k | 4.84 | |
| Fate Therapeutics (FATE) | 0.2 | $2.6M | 1.5M | 1.70 | |
| Syndax Pharmaceuticals (SNDX) | 0.2 | $2.5M | 251k | 9.85 | |
| Blueprint Medicines (BPMC) | 0.1 | $574k | 28k | 20.24 | |
| Biogen Idec (BIIB) | 0.0 | $297k | 1.2k | 241.66 | |
| Axovant Sciences | 0.0 | $321k | 25k | 12.84 | |
| LHC | 0.0 | $216k | 5.0k | 43.20 | |
| Team Health Holdings | 0.0 | $203k | 5.0k | 40.60 | |
| Aurinia Pharmaceuticals (AUPH) | 0.0 | $79k | 28k | 2.78 | |
| Adverum Biotechnologies | 0.0 | $70k | 22k | 3.15 | |
| Castlight Health | 0.0 | $41k | 10k | 4.01 |
